SNDL (SNDL) Stock Price, News & Analysis

Company Overview

SNDL Inc., formerly known as Sundial Growers Inc., is a Canada-based consumer packaged goods company focused on the production, manufacturing and distribution of cannabis products. Headquartered in Calgary, Alberta, SNDL operates multiple cultivation and processing facilities across Canada, including indoor and hybrid greenhouses in British Columbia and Ontario. The company serves both adult-use and medical cannabis markets, supplying provincial distributors as well as operating through its own wholesale and retail networks.

The company’s product portfolio spans dried flower, pre-rolls, vape cartridges, cannabis oils, edibles and infused beverages under a variety of in-house brands. SNDL has also expanded into private label and contract manufacturing for select retail partners. In 2022, SNDL completed the acquisition of Alcanna Inc., a leading beverage and cannabis distributor, adding more than 140 licensed retail outlets across four provinces. This vertical integration supports the company’s strategy to control product quality, distribution and consumer experience from seed to sale.

Founded in 2006 and going public in 2019, SNDL has grown through a combination of organic investment in cultivation capacity and strategic mergers. In 2021, the company merged with IFR Holdings, consolidating several licensed producers under a single corporate structure. SNDL continues to explore expansion in new jurisdictions, including select U.S. markets, while maintaining a primary focus on Canadian operations. Leadership is headed by President and Chief Executive Officer Zach George, supported by a team of executives with backgrounds in consumer goods, agriculture and regulated industries.

Key Stats

• Today's Range: $1.36 to $1.41
• 50-Day Range: $1.29 to $1.66
• 52-Week Range: $1.15 to $2.89
• Volume: 1.97 million shs
• Average Volume: 3.16 million shs
• Market Capitalization: $355.21 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.00
• Consensus Rating: Reduce

SNDL Stock Analysis - MarketRank™

SNDL scored higher than 56% of companies evaluated by MarketBeat, and ranked 427th out of 851 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Reduce

Consensus Rating

SNDL has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 2 sell ratings.

Upside Potential

SNDL has a consensus price target of $5.00, representing about 262.3% upside from its current price of $1.38.

Amount of Analyst Coverage

SNDL has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for SNDL are expected to grow in the coming year, from ($0.01) to $0.04 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of SNDL is -46.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of SNDL is -46.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

SNDL has a P/B Ratio of 0.45. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.82% of the float of SNDL has been sold short.

Short Interest Ratio / Days to Cover

SNDL has a short interest ratio ("days to cover") of 0.56, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SNDL has recently decreased by 1.82%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SNDL does not currently pay a dividend.

Dividend Growth

SNDL does not have a long track record of dividend growth.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

Search Interest

20 people have searched for SNDL on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.

MarketBeat Follows

5 people have added SNDL to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SNDL insiders have not sold or bought any company stock.

Percentage Held by Institutions

SNDL has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 3/12/2026
• Today: 5/19/2026
• Next Earnings (Estimated): 7/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:SNDL
• CIK: 1766600
• Web: www.sundialcannabis.com
• Phone: (844) 249-6746
• Fax: N/A
• Employees: 2,751
• Year Founded: 2006

Price Target and Rating

• Average Price Target for SNDL: $5.00
• High Price Target: $5.00
• Low Price Target: $5.00
• Potential Upside/Downside: +262.3%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$11.29 million
• Net Margins: -1.19%
• Pretax Margin: -1.38%
• Return on Equity: -1.02%
• Return on Assets: -0.85%

Debt

• Debt-to-Equity Ratio: 0.12
• Current Ratio: 4.84
• Quick Ratio: 3.25

Sales & Book Value

• Annual Sales: $677.32 million
• Price / Sales: 0.52
• Cash Flow: $0.11 per share
• Price / Cash Flow: 12.34
• Book Value: $3.08 per share
• Price / Book: 0.45

Miscellaneous

• Outstanding Shares: 257,400,000
• Free Float: N/A
• Market Cap: $355.21 million
• Optionable: Optionable
• Beta: 0.88